RegenLab® is recognized as a certified global leader in medical biotechnologies, specializing in autologous platelet-rich plasma treatment. RegenLab® is at the forefront of innovation, with an expertly designed medical device for the preparation of platelet rich plasma from the patient's own blood. RegenPRP® was developed with a focus on product quality, patient safety, and preparation efficiency. Our patient-centered technology has led to over two million treatments provided worldwide using RegenLab® products. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine.